Medical Infusion Protocols

Spravato® (Esketamine) Therapy

FDA-Approved Relief for Treatment-Resistant Depression

Spravato® (esketamine) is a prescription nasal spray, used in conjunction with an oral antidepressant, for adults with treatment-resistant depression (TRD) or depressive symptoms with acute suicidal ideation. Unlike traditional antidepressants that may take weeks to work, Spravato® targets the N-methyl-D-aspartate (NMDA) receptor to help restore synaptic connections in the brain.

Patients self-administer the spray under the supervision of our healthcare staff in a comfortable, private room. You will be monitored for at least two hours following administration to ensure safety and stability before going home.

Treatment Protocol:

The Spravato® protocol is strictly defined by the FDA REMS program and typically follows a phased approach.

Phase Duration Frequency Dosage Goal
Induction Weeks 1–4 Twice per week 56mg or 84mg Rapid symptom reduction and stabilization.
Maintenance Weeks 5–8 Once per week 56mg or 84mg Sustaining the therapeutic response.
Long-Term Week 9 onward Every 1–2 weeks 56mg or 84mg Continued management customized to patient response.
Phase Induction Duration Weeks 1–4 Frequency Twice per week Dosage 56mg or 84mg Goal Rapid symptom reduction and stabilization.
Phase Maintenance Duration Weeks 5–8 Frequency Once per week Dosage 56mg or 84mg Goal Sustaining the therapeutic response.
Phase Long-Term Duration Week 9 onward Frequency Every 1–2 weeks Dosage 56mg or 84mg Goal Continued management customized to patient response.

IV Ketamine Infusion Therapy

Rapid-Acting Treatment for Mood Disorders

Intravenous (IV) Ketamine therapy is an effective option for patients suffering from severe depression, anxiety, and PTSD who have not found relief through standard medications. Delivered directly into the bloodstream, IV Ketamine offers 100% bioavailability, allowing for precise dosing and immediate uptake by the brain.

During the infusion, you will relax in a recliner while our clinical team monitors your vitals. Many patients report a "dissociative" or dream-like state during the 40-minute treatment, which typically subsides shortly after the infusion ends.

Treatment Protocol:

While protocols may be customized, the standard "Stabilization Course" is designed to maximize neuroplasticity.

Phase Duration Frequency Description
Stabilization (Induction) 2–3 Weeks 6 infusions total (e.g., M-W-F) A concentrated series of infusions to rapidly elevate mood and disrupt depressive neural pathways.
Evaluation Week 3–4 Clinical Review Assessment of patient response to determine the need for maintenance.
Maintenance (Boosters) Ongoing Every 3–6 weeks Single infusions scheduled as needed to maintain remission and prevent relapse.
Phase Stabilization (Induction) Duration 2–3 Weeks Frequency 6 infusions total (e.g., M-W-F) Description A concentrated series of infusions to rapidly elevate mood and disrupt depressive neural pathways.
Phase Evaluation Duration Week 3–4 Frequency Clinical Review Description Assessment of patient response to determine the need for maintenance.
Phase Maintenance (Boosters) Duration Ongoing Frequency Every 3–6 weeks Description Single infusions scheduled as needed to maintain remission and prevent relapse.

IV Nutritional Therapy (Wellness Infusions)

Replenish, Hydrate, and Revitalize

Our IV Nutritional Therapy delivers vitamins, minerals, and hydration directly into your system, bypassing the digestive tract for maximum absorption. Whether you are recovering from illness, seeking athletic performance recovery, or looking to boost your immune system, our formulated cocktails are designed to restore balance to your body.

Popular Formulations:

  • Myers’ Cocktail: The "Gold Standard" for overall wellness. Contains Magnesium, Calcium, B-Vitamins, and Vitamin C.

  • Immune Boost: High-dose Vitamin C, Zinc, and antioxidants to fight fatigue and illness.

  • Basic Hydration: Pure IV Saline to restore fluid balance quickly.

Treatment Protocol:

Frequency depends on your wellness goals and current health status.

Goal Recommended Frequency Protocol Overview
Acute Recovery 1–3 sessions Administered over a few days for hangovers, jet lag, or post-viral fatigue.
Chronic Support Weekly or Bi-weekly For conditions like migraines, fatigue, or malabsorption issues.
Maintenance Monthly Routine wellness support to maintain nutrient levels and hydration.
Goal Acute Recovery Recommended Frequency 1–3 sessions Protocol Overview Administered over a few days for hangovers, jet lag, or post-viral fatigue.
Goal Chronic Support Recommended Frequency Weekly or Bi-weekly Protocol Overview For conditions like migraines, fatigue, or malabsorption issues.
Goal Maintenance Recommended Frequency Monthly Protocol Overview Routine wellness support to maintain nutrient levels and hydration.

Vivitrol® (Naltrexone) Injections

Supporting Long-Term Recovery from Opioid and Alcohol Dependence

Vivitrol® is a non-addictive, once-monthly injectable medication used to treat alcohol dependence and prevent relapse to opioid dependence. It works by blocking opioid receptors in the brain, which helps reduce cravings and blocks the pleasurable effects of opioids and alcohol.

Vivitrol® is most effective when used as part of a comprehensive recovery program that includes counseling and psychosocial support.

Treatment Protocol:

A strict detox period is required before starting Vivitrol to avoid precipitated withdrawal.

Stage Timeline Requirement Protocol Action
Pre-Treatment 7–14 days prior Crucial: Must be opioid-free Patient must stop all short-acting opioids (7 days) or long-acting opioids (14 days) to prevent withdrawal.
Induction Day 1 Negative Urine Screen Initial injection administered in the gluteal muscle.
Maintenance Monthly Every 28 Days Recurring injection to maintain receptor blockade. Counseling is highly recommended during this phase.
Stage Pre-Treatment Timeline 7–14 days prior Requirement Crucial: Must be opioid-free Protocol Action Patient must stop all short-acting opioids (7 days) or long-acting opioids (14 days) to prevent withdrawal.
Stage Induction Timeline Day 1 Requirement Negative Urine Screen Protocol Action Initial injection administered in the gluteal muscle.
Stage Maintenance Timeline Monthly Requirement Every 28 Days Protocol Action Recurring injection to maintain receptor blockade. Counseling is highly recommended during this phase.
Book Now